Vigi-Base
PharmaVigi-Base
WHO PIDM Member States submit reports of adverse reactions associated with medicinal products, known as Individual Case Safety Reports (ICSRs) to the WHO global database, VigiBase.
VigiBase is managed and maintained by the WHO Collaborating Centre for International Drug Monitoring, known as the Uppsala Monitoring Centre. In October 2014, there were over 10 million reports of adverse reactions in VigiBase. Data in VigiBase are recorded in a structured and comprehensive way to allow the detection of potential medicinal safety hazards.
The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information to assess the risk-benefit profile of medicines.
In April 2015, the WHO launched VigiAccess. It is a new web application allowing anyone to access information and encourages the reporting of adverse effects from medicinal products.